Racial differences in ceramides, cardiovascular health and cardiovascular risk: A preliminary analysis
No association was observed between ceramide scores and CVH or ASCVD risk in African-American adults. Despite having a less favorable cardiometabolic profile, African-Americans exhibited lower ceramide levels than White adults. These findings suggest that ceramide scores may not accurately reflect cardiovascular risk in African-American populations.
Authors
- Matthew P. Johnson (ORCID: https://orcid.org/0000-0002-6341-7220)
- Vlad C. Vasile (ORCID: https://orcid.org/0000-0001-5447-8091)
- Christi A. Patten (ORCID: https://orcid.org/0000-0002-7194-8160)
- Mathias Lalika (ORCID: https://orcid.org/0000-0003-0229-9942)
- LaPrincess C. Brewer (ORCID: https://orcid.org/0000-0002-6468-9324)
- Sharonne N. Hayes (ORCID: https://orcid.org/0000-0003-3129-362X)
- Lisa A. Cooper
- Clarence Jones
Institutions
- Mayo Clinic (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Hmong American Partnership (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Advances in Clinical and Experimental Medicine
- Published
- 2026-01-07
- DOI
- https://doi.org/10.17219/acem/211134
- Primary Topic
- Sphingolipid Metabolism and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00